Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0900
-0.0040 (-4.27%)
Aug 1, 2025, 2:08 PM EDT
Bioxytran Market Cap
Bioxytran has a market cap or net worth of $8.01 million as of August 1, 2025. Its market cap has decreased by -46.57% in one year.
Market Cap
8.01M
Enterprise Value
9.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since September 24, 2018, Bioxytran's market cap has decreased from 25.52M to 8.01M, a decrease of -68.62%. That is a compound annual growth rate of -15.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 8.01M | 2.66% |
| Dec 31, 2024 | 7.80M | -64.29% |
| Dec 29, 2023 | 21.85M | -63.00% |
| Dec 30, 2022 | 59.05M | 33.18% |
| Dec 31, 2021 | 44.34M | 89.57% |
| Dec 30, 2020 | 23.39M | -4.77% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 396.28M |
| CytoDyn | 371.08M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |